Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...
Alexander Spira, MD, PhD, FACP provides an overview of molecular testing in NSCLC. Alexander Spira, MD, PhD, FACP: Guidelines and recommendations around molecular testing in advanced non-small cell ...
A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...
SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
ROCKVILLE, Md. – August 19, 2024 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, and world-renowned pathologist Michael Laposata, MD, PhD ...
Zacks Investment Research on MSN
OraSure files for FDA review of molecular self-test & Colli-Pee device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...
The Eonis™ Q system from Revvity is an innovative dry PCR workflow that simplifies and streamlines molecular testing for SMA and SCID. It comprises the compact Eonis™ Q96 instrument, stable and ...
To permanently access this eBook for free, fill out the short form below. Ready to revolutionise your molecular testing for myeloid malignancies? With a constantly expanding list of biomarkers, ...
Pneumonia is an inflammatory condition affecting the lungs, typically resulting from an infection with viruses or bacteria. Community-acquired pneumonia refers to pneumonia acquired outside of the ...
3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results